Olema Pharmaceuticals, Inc. (OLMA)
USD 5.85
(-4.72%)
USD 5.85
(-4.72%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -83.72 Million | -82.06 Million | -50.69 Million | -19.86 Million | -3.08 Million | -2.17 Million |
| Net Income | -96.65 Million | -104.78 Million | -71.09 Million | -22.12 Million | -4.31 Million | -2.19 Million |
| Depreciation & Amortization | 377 Thousand | 357 Thousand | 163 Thousand | 11 Thousand | 9000.00 | 8000.00 |
| Deferred income taxes | -2.32 Million | - | 276 Thousand | - | - | - |
| Stock-based compensation | 17.25 Million | 18.82 Million | 15.91 Million | 3.1 Million | - | 1000.00 |
| Change in working capital | -589 Thousand | 3.02 Million | 2.83 Million | -1.5 Million | 1.22 Million | -110 Thousand |
| Other non-cash items | -1.79 Million | 514 Thousand | 1.22 Million | 641 Thousand | -1.14 Million | 122 Thousand |
| Investing Cash Flow | -4.85 Million | 91.47 Million | -275.43 Million | -56 Thousand | - | - |
| Investments in PPE | - | -363 Thousand | -1.57 Million | -56 Thousand | - | - |
| Acquisitions | - | 363 Thousand | 1.57 Million | - | - | - |
| Investment purchases | -255.62 Million | -213.66 Million | -486.96 Million | - | - | - |
| Sales/Maturities of investments | 250.76 Million | 305.5 Million | 213.1 Million | - | - | - |
| Other Investing Activities | 14 Thousand | -363 Thousand | -1.57 Million | -56 Thousand | - | - |
| Financing Cash Flow | 133.41 Million | 476 Thousand | 1.39 Million | 358.4 Million | - | 5.25 Million |
| Debt repayment | - | - | - | -3.08 Million | - | -323 Thousand |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | -2.28 Million | - | - |
| Common Stock Issuance | 133.41 Million | 330 Thousand | 721 Thousand | 220.55 Million | - | 5.25 Million |
| Other Financing Activities | 132.36 Million | 146 Thousand | 670 Thousand | 143.23 Million | - | 5.25 Million |
| Accounts receivables | - | - | - | - | - | - |
| Accounts payables | 2.32 Million | 351 Thousand | -683 Thousand | -220 Thousand | 1.16 Million | -100 Thousand |
| Inventory | - | - | - | - | - | - |
| Other working capital | -2.91 Million | 2.67 Million | 3.51 Million | -1.28 Million | 58 Thousand | -10 Thousand |
| Cash at beginning of period | 23.7 Million | 13.81 Million | 338.54 Million | 68 Thousand | 3.14 Million | 71 Thousand |
| Cash at end of period | 68.53 Million | 23.7 Million | 13.81 Million | 338.54 Million | 68 Thousand | 3.14 Million |
| Capital Expenditure | - | -363 Thousand | -1.57 Million | -56 Thousand | - | - |
| Effect of forex changes on cash | 1.00 | - | - | - | - | - |
| Net cash flow / Change in cash | 44.83 Million | 9.89 Million | -324.73 Million | 338.48 Million | -3.08 Million | 3.07 Million |
| Free Cash Flow | -83.72 Million | -82.42 Million | -52.26 Million | -19.92 Million | -3.08 Million | -2.17 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -30.38 Million | -30.97 Million | -96.65 Million | -26.77 Million | -21.5 Million | -20.09 Million |
| Depreciation & Amortization | 94 Thousand | 88 Thousand | 377 Thousand | 88 Thousand | 90 Thousand | 99 Thousand |
| Deferred income taxes | - | - | -2.32 Million | -4.03 Million | -1.17 Million | -1.09 Million |
| Stock-based compensation | 5.72 Million | 4.9 Million | 17.25 Million | 4.35 Million | 4.1 Million | 4.17 Million |
| Change in working capital | -1.08 Million | 4.54 Million | -589 Thousand | 5.8 Million | -4.57 Million | -5.52 Million |
| Other non-cash items | 7.31 Million | -2.06 Million | -1.79 Million | 2.08 Million | 320 Thousand | 326 Thousand |
| Investing Cash Flow | -4.87 Million | -20.14 Million | -4.85 Million | -30.91 Million | -25.43 Million | 14.11 Million |
| Investments in PPE | -6000.00 | -153 Thousand | - | - | - | - |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | -82.16 Million | -76.09 Million | -255.62 Million | -84.91 Million | -95.95 Million | -50.38 Million |
| Sales/Maturities of investments | 77.29 Million | 56.1 Million | 250.76 Million | 54 Million | 70.5 Million | 64.5 Million |
| Other Investing Activities | -4.87 Million | -153 Thousand | 14 Thousand | -30.91 Thousand | 14 Thousand | 14.11 Thousand |
| Financing Cash Flow | 15.6 Million | 8.82 Million | 133.41 Million | 523 Thousand | 130.62 Million | 2.04 Million |
| Debt repayment | - | - | - | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 15.6 Million | 7.9 Million | 133.41 Million | 523 Thousand | 130.62 Million | 2.04 Million |
| Other Financing Activities | 15.6 Million | 8.82 Million | 132.36 Million | 523.00 | 1.00 | 2043.00 |
| Accounts receivables | - | - | - | - | - | - |
| Accounts payables | -3.3 Million | 4.95 Million | 2.32 Million | 491 Thousand | 582 Thousand | 944 Thousand |
| Inventory | - | - | - | - | - | - |
| Other working capital | 2.21 Million | -414 Thousand | -2.91 Million | 5.31 Million | -5.16 Million | -6.46 Million |
| Cash at beginning of period | 33.72 Million | 68.53 Million | 23.7 Million | 117.4 Million | 34.95 Million | 40.91 Million |
| Cash at end of period | 16.89 Million | 33.72 Million | 68.53 Million | 68.53 Million | 117.4 Million | 34.95 Million |
| Capital Expenditure | -6000.00 | -153 Thousand | - | - | - | - |
| Effect of forex changes on cash | - | - | 1.00 | - | - | - |
| Net cash flow / Change in cash | -16.82 Million | -34.81 Million | 44.83 Million | -48.86 Million | 82.44 Million | -5.96 Million |
| Free Cash Flow | -27.56 Million | -23.64 Million | -83.72 Million | -18.47 Million | -22.74 Million | -22.11 Million |
GCTK
VIPCLOTHNG
ZUARIIND
SCHAEFFLER
PRIVISCL
IIQ